0.5 mL IM inj as single dose. Primary vaccination Individual 2-55 yrGiven as single dose. Childn 9-23 mth 2-dose series at least 3 mth apart. Booster vaccination Individual 15-55 yr at continued risk for meningococcal disease Single booster dose, at least 4 yr have elapsed since prior dose.
Hypersensitivity. Not to be inj IV, SC or intradermally. Guillain-Barre syndrome; thrombocytopenia or bleeding disorders. Immunocompromised patients including those receiving immunosuppressant therapy. Syncope. Complement deficiency. Pregnancy & lactation. Not to be used in infants <9 mth. Elderly >55 yr.
J07AH08 - meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated ; Belongs to the class of meningococcal bacterial vaccines.
Sign Out
 0.5 mL_dose3e2a1a65-0733-4a8c-a9d2-a1b00137f0ea.GIF)
